Xaidi AG

Neurodivergent individuals, including those with ADHD and autism, often lack access to personalised, continuous support.

Xaidi is a B2B AI-powered health platform that enables healthcare providers, insurers, and government agencies to deliver evidence-based, personalised care for neurodivergent individuals and their families.

Active in Qatar since January 2026 with leading healthcare institutions, Xaidi is now expanding across the Middle East, Europe, and Southeast Asia.

Built on responsible AI and co-developed with clinicians and users, the platform combines digital coaching, therapy access, telemedicine, and community resources. HIPAA-compliant and clinically validated.